Does Campylobacter infection have neurological sequelae?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Yes, campylobacter infection can cause neurological sequelae, with the most significant complication being Guillain-Barré syndrome (GBS), which occurs in approximately 1 in 1,000 cases of Campylobacter jejuni infection, as supported by a study published in the Journal of autoimmunity in 2017 1.

Key Points

  • The risk of developing neurological sequelae is associated with specific Campylobacter serotypes, particularly those with sialic acid-containing lipooligosaccharides.
  • GBS typically develops 1-3 weeks after the initial gastrointestinal symptoms and presents as ascending paralysis with areflexia.
  • Other neurological complications include Miller Fisher syndrome, Bickerstaff's encephalitis, and acute transverse myelitis.
  • These complications occur because molecular mimicry between Campylobacter lipopolysaccharides and human gangliosides triggers an autoimmune response targeting peripheral nerves.

Evidence

  • A study published in the Journal of child neurology in 2009 found evidence of recent Campylobacter jejuni infection in 27.7% of patients with Guillain-Barré syndrome, as compared with 2.3% in neurological controls and 2.3% in nonneurological controls 2.
  • Another study published in Clinical microbiology reviews in 1998 found that Campylobacter infection is the single most identifiable antecedent infection associated with the development of GBS, and that different strains of Campylobacter as well as host factors likely play an important role in determining who develops GBS 3.

Treatment and Management

  • Treatment of the initial infection with appropriate antibiotics (macrolides like azithromycin 500mg daily for 3 days or fluoroquinolones) may reduce bacterial load but has not been definitively proven to prevent neurological complications once the immune response is triggered.
  • Patients with campylobacter infection who develop neurological symptoms such as muscle weakness, numbness, tingling, or coordination problems should seek immediate medical attention for proper diagnosis and management.

Important Considerations

  • The association between Campylobacter infection and neurological sequelae is well-established, and patients with campylobacter infection should be monitored closely for signs of neurological complications.
  • Further research is needed to fully understand the mechanisms underlying the development of neurological sequelae after Campylobacter infection, and to develop effective strategies for prevention and treatment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.